Recombinant CD37 (Naratuximab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Target See all CD37 (Naratuximab Biosimilar) products
- CD37 (Naratuximab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Humanized
- Expression System
- Mammalian cells
-
Clonality
- Chimeric
-
Conjugate
- This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CD37 (Naratuximab Biosimilar)
- Abstract
- CD37 (Naratuximab Biosimilar) Products
- Background
- Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.
- CAS-No
- 1622327-39-2
-
You are here:
